Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile
Javier Cabrera Sanchez

@javiercabrera_s

🇵🇪 Medical Student (7/7) at @CayetanoHeredia |Internal Medicine |🔬

ID: 1403826829

calendar_today05-05-2013 01:38:02

270 Tweet

157 Followers

273 Following

The Lancet (@thelancet) 's Twitter Profile Photo

NEW—Most symptoms of #COVID19 in hospitalised patients are resolved within 12 months, however, around one of patients half still experience at least one persistent symptom: finding from a study of 1276 patients from Wuhan, China hubs.li/H0W299T0

NEW—Most symptoms of #COVID19 in hospitalised patients are resolved within 12 months, however, around one of patients half still experience at least one persistent symptom: finding from a study of 1276 patients from Wuhan, China 
hubs.li/H0W299T0
Dr Alfonso J Rodriguez-Morales MD MSc DTM&H HonDSc (@drajrodriguezm) 's Twitter Profile Photo

Finalmente en línea! Herrera-Añazco P, et al. Prevalencia y factores asociados a la intención de vacunación contra la COVID-19 en el Perú. Rev Peru Med Exp Salud Publica 2021 Epub Ahead Aug 26; rpmesp.ins.gob.pe/rpmesp/article… Vicente Aleixandre Silamud ACINNACIONAL @APIinfectologia

Finalmente en línea!
Herrera-Añazco P, et al. Prevalencia y factores asociados a la intención de vacunación contra la COVID-19 en el Perú. Rev Peru Med Exp Salud Publica 2021 Epub Ahead Aug 26; rpmesp.ins.gob.pe/rpmesp/article… <a href="/Vizenttiko/">Vicente Aleixandre</a> <a href="/silamud75/">Silamud</a> <a href="/acinnacional/">ACINNACIONAL</a> <a href="/apiinfectologia/">@APIinfectologia</a>
Percy Mayta-Tristán (@maytatristan) 's Twitter Profile Photo

La mortalidad de pacientes hospitalizados por covid-19 en Perú según estado de inmunización antes de la hospitalización: No inmunizados: 45.19% fallecen Inmunización parcial (14 o + días 1a dosis): 0.76% fallecen Inmunización completa(14 o + días 2a dosis): 0.24% fallecen

La mortalidad de pacientes hospitalizados por covid-19 en Perú según estado de inmunización antes de la hospitalización:
No inmunizados: 45.19% fallecen

Inmunización parcial (14 o + días 1a dosis):  0.76% fallecen

Inmunización completa(14 o + días 2a dosis): 0.24% fallecen
saludconlupa.com (@saludconlupa) 's Twitter Profile Photo

Mientras miles acuden a vacunarse contra la covid-19, grupos de Médicos por la Verdad hacen actividades con niños e invocan a no usar mascarillas y no vacunarse. En sus grupos reportan que estarán esta tarde en la Plaza de Armas de Villa El Salvador.Ministerio Público Ministerio de Salud

Mientras miles acuden a vacunarse contra la covid-19, grupos de Médicos por la Verdad hacen actividades con niños e invocan a no usar mascarillas y no vacunarse.

En sus grupos reportan que estarán esta tarde en la Plaza de Armas de Villa El Salvador.<a href="/FiscaliaPeru/">Ministerio Público</a> <a href="/Minsa_Peru/">Ministerio de Salud</a>
Johns Hopkins Bloomberg School of Public Health (@johnshopkinssph) 's Twitter Profile Photo

"This is a moment to prioritize health over short-term political calculations," write @DrJoshS, Prof Peter Hotez MD PhD DSc(hon), and others in The Lancet. "SARS-CoV-2 is agnostic in whom it infects, and COVID-19 vaccines protect liberals and conservatives alike." thelancet.com/journals/lance…

"This is a moment to prioritize health over short-term political calculations," write @DrJoshS, <a href="/PeterHotez/">Prof Peter Hotez MD PhD DSc(hon)</a>, and others in <a href="/TheLancet/">The Lancet</a>.

"SARS-CoV-2 is agnostic in whom it infects, and COVID-19 vaccines protect liberals and conservatives alike." thelancet.com/journals/lance…
Alvaro Taype-Rondan (@alvaro_taype) 's Twitter Profile Photo

Ojo, esto es de interés nacional📌 La actual dirección del CMP poco tiempo antes de finalizar, está a punto de aprobar un nuevo Código de Ética y Deontología, más flexible con las pseudociencias, uso de fármacos sin evidencia, y con otras sorpresas horrorosas. (1/10)

Ojo, esto es de interés nacional📌

La actual dirección del CMP poco tiempo antes de finalizar, está a punto de aprobar un nuevo Código de Ética y Deontología, más flexible con las pseudociencias, uso de fármacos sin evidencia, y con otras sorpresas horrorosas. (1/10)
Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile Photo

Happy to share that my first research poster was accepted to be presented at the 52nd World Conference on Lung Health (The Union Conference). Evidence is growing on post-tuberculosis lung health. I will present our study on the association between TB and lung cancer. #UnionConf

Happy to share that my first research poster was accepted to be presented at the 52nd World Conference on Lung Health (<a href="/UnionConference/">The Union Conference</a>). Evidence is growing on post-tuberculosis lung health. I will present our study on the association between TB and lung cancer. #UnionConf
Carlos Andrés Celis-Preciado (@pulmonology101) 's Twitter Profile Photo

#Asthma is a heterogenous disease. Targeted therapies have been developed based on the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of T2 airway diseases. bit.ly/3HCkrvQ Arzu Yorgancıoğlu Hospital Universitario San Ignacio ALAT Asma Global Initiative for Asthma (GINA)

#Asthma is a heterogenous disease. Targeted therapies have been developed based on the pathophysiology of type 2 inflammation. These therapies offer hope for improved management of T2 airway diseases. bit.ly/3HCkrvQ <a href="/ArzuYorgancolu/">Arzu Yorgancıoğlu</a> <a href="/HUSI_Investiga/">Hospital Universitario San Ignacio</a> <a href="/ALAT_Asma/">ALAT Asma</a> <a href="/ginasthma/">Global Initiative for Asthma (GINA)</a>
Inst. de Medicina Tropical Alexander von Humboldt (@imtavh_upch) 's Twitter Profile Photo

📌Los invitamos a ver la ultima publicación del IMTAvH: Ocurrencia de cáncer de pulmón después de un episodio de tuberculosis: una revisión sistemática y metanálisis Javier Cabrera Sanchez, Dr. Vicente Cuba, Victor Vega Zambrano ,Dra. Larissa Otero, Dr. Patrick Van err.ersjournals.com/content/31/165…

Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile Photo

Hey, #MedTwitter 👋 I am looking for collaborators (from the countries below) for a study about respiratory medicines in LMICs. If someone is interested or knows someone who may be, please let me know! 👉Belize, Cuba, Dominican Republic, El Salvador, Guatemala, Haiti

Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile Photo

Peru reported one of the highest excess death rates worldwide during the COVID-19 pandemic. I will speak at the 52nd The Union Conference and present the findings of a study on mortality rates and socioeconomic status in the largest city of Peru. Victor Vega Zambrano #UnionConf

Peru reported one of the highest excess death rates worldwide during the COVID-19 pandemic. I will speak at the 52nd <a href="/UnionConference/">The Union Conference</a> and present the findings of a study on mortality rates and socioeconomic status in the largest city of Peru. <a href="/VictorVegaZ/">Victor Vega Zambrano</a> 
#UnionConf
Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile Photo

Had an amazing experience presenting a case for the The Clinical Problem Solvers today! Learned so much from the insights shared by the awesome discussants (Jas Bajwa and @DrMengyu). Had fun interacting with everyone in the chat. Thanks for the opportunity! 🌟

Javier Cabrera Sanchez (@javiercabrera_s) 's Twitter Profile Photo

🎓 Officially graduated from medical school this April, but just received this photo from the university. Grateful for the journey, the challenges, and everyone who supported me along the way. Excited for what’s ahead! #MedTwitter #MedicalGraduate

🎓 Officially graduated from medical school this April, but just received this photo from the university.

Grateful for the journey, the challenges, and everyone who supported me along the way.

Excited for what’s ahead!

#MedTwitter #MedicalGraduate